Keeping up the balance: role of HDACs in cardiac proteostasis and therapeutic implications for atrial fibrillation

Deli Zhang, Xu Hu, Robert H Henning, Bianca J J M Brundel*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

18 Citations (Scopus)

Abstract

Cardiomyocytes are long-lived post-mitotic cells with limited regenerative capacity. Proper cardiomyocyte function depends critically on the maintenance of a healthy homeostasis of protein expression, folding, assembly, trafficking, function, and degradation, together commonly referred to as proteostasis. Impairment of proteostasis has a prominent role in the pathophysiology of ageing-related neurodegenerative diseases including Huntington's, Parkinson's, and Alzheimer's disease. Emerging evidence reveals also a role for impaired proteostasis in the pathophysiology of common human cardiac diseases such as cardiac hypertrophy, dilated and ischaemic cardiomyopathies, and atrial fibrillation (AF). Histone deacetylases (HDACs) have recently been recognized as key modulators which control cardiac proteostasis by deacetylating various proteins. By deacetylating chromatin proteins, including histones, HDACs modulate epigenetic regulation of pathological gene expression. Also, HDACs exert a broad range of functions outside the nucleus by deacetylating structural and contractile proteins. The cytosolic actions of HDACs result in changed protein function through post-translational modifications and/or modulation of their degradation. This review describes the mechanisms underlying the derailment of proteostasis in AF and subsequently focuses on the role of HDACs herein. In addition, the therapeutic potential of HDAC inhibition to maintain a healthy proteostasis resulting in a delay in AF onset and progression is discussed.

Original languageEnglish
Pages (from-to)519-526
Number of pages8
JournalCardiovascular Research
Volume109
Issue number4
DOIs
Publication statusPublished - 1-Apr-2016

Keywords

  • Atrial fibrillation
  • Histone deacetylases
  • Proteostasis
  • HDAC6
  • HISTONE-DEACETYLASE INHIBITION
  • ANGIOTENSIN-CONVERTING ENZYME
  • HEAT-SHOCK PROTEINS
  • STRUCTURAL-CHANGES
  • GENE-EXPRESSION
  • CONTRACTILE DYSFUNCTION
  • POSTTRANSLATIONAL MODIFICATIONS
  • CARDIOMYOCYTE HYPERTROPHY
  • HEMATOLOGIC MALIGNANCIES
  • TRANSCRIPTION FACTOR

Cite this